BOMBAY SUPER HYBRID SEEDS
|
BOMBAY SUPER HYBRID SEEDS Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.52 | 2.12 | 1.60 | 10.01 | 5.53 |
| CEPS(Rs) | 2.64 | 2.25 | 1.73 | 1.13 | 0.69 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 9.98 | 7.46 | 5.37 | 37.63 | 27.58 |
| Tax Rate(%) | 5.91 | 5.57 | 5.90 | 4.72 | 5.04 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.13 | 11.08 | 9.44 | 7.19 | 4.81 |
| EBIT Margin(%) | 9.54 | 10.94 | 9.16 | 6.74 | 4.24 |
| Pre Tax Margin(%) | 7.82 | 9.16 | 7.82 | 5.75 | 3.49 |
| PAT Margin (%) | 7.36 | 8.65 | 7.36 | 5.48 | 3.32 |
| Cash Profit Margin (%) | 7.72 | 9.17 | 7.95 | 6.16 | 4.12 |
| Performance Ratios | |||||
| ROA(%) | 13.73 | 15.10 | 14.56 | 12.32 | 9.72 |
| ROE(%) | 28.86 | 33.01 | 35.02 | 30.70 | 22.30 |
| ROCE(%) | 21.19 | 23.88 | 22.18 | 18.69 | 15.14 |
| Asset Turnover(x) | 1.87 | 1.75 | 1.98 | 2.25 | 2.93 |
| Sales/Fixed Asset(x) | 26.88 | 15.50 | 15.09 | 14.01 | 13.21 |
| Working Capital/Sales(x) | 3.72 | 3.59 | 4.71 | 5.72 | 7.42 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.04 | 0.06 | 0.07 | 0.07 | 0.08 |
| Receivable days | 8.53 | 13.24 | 19.78 | 22.47 | 15.29 |
| Inventory Days | 170.42 | 180.50 | 146.75 | 111.89 | 79.79 |
| Payable days | 19.09 | 30.24 | 41.68 | 18.73 | 6.00 |
| Valuation Parameters | |||||
| PER(x) | 48.03 | 105.05 | 229.93 | 3.92 | 2.53 |
| PCE(x) | 45.77 | 99.06 | 212.85 | 34.87 | 20.39 |
| Price/Book(x) | 12.12 | 29.81 | 68.49 | 10.43 | 5.07 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 3.79 | 9.27 | 17.16 | 2.35 | 1.00 |
| EV/Core EBITDA(x) | 38.28 | 80.86 | 176.08 | 31.70 | 19.50 |
| EV/EBIT(x) | 39.74 | 84.72 | 187.44 | 34.92 | 23.19 |
| EV/CE(x) | 6.91 | 18.86 | 35.83 | 4.61 | 2.37 |
| M Cap / Sales | 3.54 | 9.09 | 16.93 | 2.15 | 0.86 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 39.66 | 12.71 | 18.88 | 11.89 | 65.95 |
| Core EBITDA Growth(%) | 20.66 | 32.59 | 56.04 | 61.40 | 41.88 |
| EBIT Growth(%) | 21.77 | 34.71 | 61.49 | 74.20 | 57.34 |
| PAT Growth(%) | 18.86 | 32.38 | 59.77 | 81.13 | 117.63 |
| EPS Growth(%) | 18.85 | 32.39 | -84.02 | 81.13 | 63.22 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.88 | 0.61 | 0.94 | 1.00 | 1.05 |
| Current Ratio(x) | 1.82 | 1.87 | 1.64 | 1.59 | 1.58 |
| Quick Ratio(x) | 0.17 | 0.17 | 0.13 | 0.37 | 0.40 |
| Interest Cover(x) | 5.55 | 6.13 | 6.88 | 6.81 | 5.66 |
| Total Debt/Mcap(x) | 0.07 | 0.02 | 0.01 | 0.10 | 0.21 |
Compare Financial Ratios of peers of BOMBAY SUPER HYBRID SEEDS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BOMBAY SUPER HYBRID SEEDS | ₹1,362.2 Cr | -3% | -3.8% | -29.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,324.7 Cr | -1.6% | 3.7% | -28.2% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,929.4 Cr | -3.5% | 0.1% | 10.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,121.8 Cr | 0.7% | 2% | -32.8% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹523.0 Cr | -0.9% | -2% | NA | Stock Analytics | |
| INDO US BIOTECH | ₹283.4 Cr | -2.2% | -6.1% | -56.5% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BOMBAY SUPER HYBRID SEEDS | -3% |
-3.8% |
-29.8% |
| SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses
